Literature DB >> 22997449

Management of chemotherapy extravasation: ESMO-EONS Clinical Practice Guidelines.

J A Pérez Fidalgo1, L García Fabregat, A Cervantes, A Margulies, C Vidall, F Roila.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22997449     DOI: 10.1093/annonc/mds294

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  24 in total

1.  Management of extravasation of oxaliplatin by mimicking its biotransformation.

Authors:  F Bahadori; M Demiray
Journal:  Clin Transl Oncol       Date:  2018-04-27       Impact factor: 3.405

Review 2.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

Review 3.  [Oncological emergencies in chemotherapy : Febrile neutropenia, tumor lysis syndrome, and extravasation].

Authors:  G von Amsberg
Journal:  Urologe A       Date:  2018-05       Impact factor: 0.639

4.  Cervical dissecting extravasation of oxaliplatin: A case report.

Authors:  Jorge Hernando; Judit Riera-Arnau; Maria Roca; Alejandro Garcia; Jaume Capdevila
Journal:  Mol Clin Oncol       Date:  2022-01-12

Review 5.  Medication Safety Systems and the Important Role of Pharmacists.

Authors:  Jeannell M Mansur
Journal:  Drugs Aging       Date:  2016-03       Impact factor: 3.923

Review 6.  Treatment of anthracycline extravasations using dexrazoxane.

Authors:  D Conde-Estévez; J Mateu-de Antonio
Journal:  Clin Transl Oncol       Date:  2013-08-15       Impact factor: 3.405

7.  Tissue distribution of epirubicin after severe extravasation in humans.

Authors:  Jakob Nedomansky; Werner Haslik; Ursula Pluschnig; Christoph Kornauth; Christine Deutschmann; Stefan Hacker; Günther G Steger; Rupert Bartsch; Robert M Mader
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-27       Impact factor: 3.333

8.  Inherent and modifiable risk factors for peripheral venous catheter failure during cancer treatment: a prospective cohort study.

Authors:  Emily N Larsen; Nicole Marsh; Catherine O'Brien; Emily Monteagle; Christopher Friese; Claire M Rickard
Journal:  Support Care Cancer       Date:  2020-07-24       Impact factor: 3.603

9.  Efficacy of combination of localized closure, ethacridine lactate dressing, and phototherapy in treatment of severe extravasation injuries: A case series.

Authors:  Yan-Xu Lu; Ying Wu; Peng-Fei Liang; Rong-Chan Wu; Ling-Yun Tian; Hui-Ying Mo
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

10.  Outcomes and Management of Peripheral Intravenous Infiltration Injuries.

Authors:  Joseph T Gibian; Danny Zakria; Cooper March; Basil Schaheen; Brian C Drolet
Journal:  Hand (N Y)       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.